Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 3,257

Document Document Title
WO/2024/065048A1
The present disclosure relates to sweetened fibers, compositions thereof, and products comprising the sweetened fiber of the present disclosure, and uses thereof. The present disclosure also relates to methods of preparing the sweetened ...  
WO/2024/062148A1
The present invention relates to a process for producing hemicellulose-derived products from a lignocellulose material, said process comprising an alkaline pretreatment of said lignocellulose material to produce a hydrolysable solid, and...  
WO/2024/053574A1
[Problem] The present invention addresses the problem of providing a novel oligosaccharide that is a two-branched glycan that has an α2,6-sialic acid structure at the non-reducing end, a production method for the oligosaccharide, an int...  
WO/2024/042235A1
The present disclosure relates to a method for producing oligosaccharides where the method combines a fermentation process and an enzymatic reaction in the medium of the fermentation, thereby enabling the formation of the oligosaccharide...  
WO/2024/036637A1
The present invention relates to the field of biochemistry, and specifically to a preparation method for a sodium hyaluronate oligosaccharide composition. Further disclosed are a prepared composition and a use. The preparation method for...  
WO/2024/014657A1
The present invention provides a method for producing D-allulose crystals, comprising the steps of adding D-allulose seed crystals to a D-allulose-containing stock solution, and then carrying out a crystallization reaction under a temper...  
WO/2024/008701A1
The present invention relates to a method of removing calcium citrate from a liquid dairy stream. In particular, the present invention relates to a method of removing calcium citrate from a liquid dairy stream wherein the liquid dairy st...  
WO/2024/003840A1
The present application relates to a process for producing glucose comprising reacting water and carbon from a carbon source in the presence of a melanin device, which comprises melanin and a substrate material (e.g., silica, plastic, or...  
WO/2023/242192A1
The invention relates to a syrup comprising one or more cellooligosaccharides in dissolved form at an overall content of at least 10 wt.-%, preferably at least 12.5 wt.-%, more preferably at least 50 wt.-%, relative to the total weight o...  
WO/2023/240111A1
The present invention provides modified sophorolipids of formula (I) that are more pH- and temperature-stable than its lactonic counterparts. Moreover, the compound has reduced HLB parameters, as well as improved wetting and solubilizati...  
WO/2023/225364A1
The invention provides methods for glycosylation and preparation of compounds. The compounds include galactosylated, sialylated, fucosylated, and N-acetylglucosaminylated compounds from simple animal-derived, plant-derived, or microbe-de...  
WO/2023/198436A2
Described herein are compound useful as sweet flavor modifiers. Ingestible compositions that include one or more of these compounds in combination with a natural or artificial sweetener are also described.  
WO/2023/174422A1
The present invention belongs to the technical field of crystal products, and relates to high-purity crystalline D-tagatose, a composition comprising same, a method for preparing same, and use thereof. Specifically, the crystalline D-tag...  
WO/2023/176952A1
The purpose of the present invention is to provide a means for controlling the proliferation of a bacterium in the intestine. Provided is a composition for controlling the proliferation of any one bacterium selected from the group consis...  
WO/2023/176951A1
Provided is a means for controlling proliferation of Collinsella bacteria in the intestines. The present invention addresses the problem of providing a novel material that is capable of controlling proliferation of Collinsella bacteria. ...  
WO/2023/176950A1
Provided is a means for controlling the proliferation of any one bacterium selected from the group consisting of a bacterium belonging to the genus Faecalibacterium, a bacterium belonging to the genus Akkermansia, a bacterium belonging t...  
WO/2023/168607A1
A compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition thereof are provided, wherein the compound includes a retinoic acid conjugated with a carbohydrate. In addition, use of the compound or the pharma...  
WO/2023/170250A1
The invention relates to an enzymatic process for the preparation and purification of lactulose starting from lactose using cellobiose-2-epimerase (EC 5.1.3.11) followed by converting lactose to monosaccharides using lactase (EC 3.2.1.10...  
WO/2023/170426A1
A prebiotic oligosaccharide composition. The composition comprises oligosaccharide compounds, for example galactooligosaccharide compounds, which includes: (a) at least 8 wt% Gal-(β1-3)-Gal-(β1-4)-Xa; (b) at least 3 wt% Gal-(β1-3)-Gal...  
WO/2023/147789A1
Disclosed in the present invention is a chemical synthesis method of chitosan oligosaccharide with a controllable polymerization degree, which belongs to the field of sugar chemistry. The method of the present invention comprises the fol...  
WO/2023/135229A1
The present invention relates to a polypeptide with at least 85% sequence identity to SEQ ID NO: 1, as an endo-ß-1,4-xylanase (EC 3.2.1.8) having transglycosylation activity. Preferably, said polypeptide is obtained from Rhamnusium bico...  
WO/2023/130594A1
The present invention relates to L-arabinose as well as a preparation and the use thereof. The L-arabinose and the preparation thereof are prepared by means of the following process: (1) dissolving an L-arabinose raw material in water, a...  
WO/2023/123805A1
The present invention relates to a system for preparing refined xylose and fermentable sugar by using corn straw. The system comprises a premix tank, an alkali treatment tank, an acid hydrolysis tank, an enzymatic hydrolysis tank, a neut...  
WO/2023/124706A1
The present application relates to the field of deep processing of dairy products, in particular to a method for preparing a milk oligosaccharide, a milk oligosaccharide powder prepared using same, and food. The preparation method compri...  
WO/2023/125505A1
The present invention provides a method for preparing stachyose, which method belongs to the technical field of the production of carbohydrates. The method comprises: breaking the wall of Stachys affinis; subjecting the resulting wall-br...  
WO/2023/118961A1
The present disclosure is directed toward drugs and toxins functionalized by at least one saccharide, sulfate or sulfonate; drug conjugates comprising said drugs or toxins and a cleavable linker; and targeted conjugates comprising said d...  
WO/2023/116302A1
The present invention relates to a method for co-producing erythritol and arabinose from a xylose mother liquor. Xylose is separated by means of first chromatographic separation to obtain an extract solution and a raffinate, the extract ...  
WO/2023/118187A1
The present invention relates to a process for preparing a dried carbohydrate preparation from a water-containing crystalline carbohydrate starting preparation and carbohydrate particles, and to the carbohydrate preparation prepared by t...  
WO/2023/119199A1
The present invention relates to a method for producing a nonfat milk solid extract on an industrial scale from a source of lactose, wherein the source of lactose is subjected to a pre-concentration, hydrolysis, pasteurisation, concentra...  
WO/2023/114315A1
The invention provides methods and compositions for treating a parasitic infection in an animal.  
WO/2023/093337A1
The present invention discloses a genetically engineered bacteria, which is E. coli integrated with lysogenic λDE3, and lacZ gene is completely inactivated, but does not affect exogenous protein expression of the genetically engineered ...  
WO/2023/083977A1
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a...  
WO/2023/070223A1
The invention provides for a vaccine against S. suis serotype 2. The vaccine comprises chemically synthesized fragments and thus may be made widely commercially available. The vaccine is used in the livestock production and may be adapte...  
WO/2023/069858A1
Methods for controlled synthesis and chemical recycling of stereoregular polysaccharides via polymerization of biomass-derived anhydrosugars are provided. The anhydrosugars react with an initiator in the presence of a synergy of a cataly...  
WO/2023/066907A1
A method for providing a solid amorphous HMO product, said method including drying an aqueous composition of said HMO. Solid amorphous HMO product is obtained via said method, as well as solid amorphous HMO product per se.  
WO/2023/063364A1
The purpose of the present invention is to provide a technology useful for sugar synthesis, the technology using formaldehyde as the main raw material and allowing for selective promotion of the formose reaction. This method for produc...  
WO/2023/064751A1
The present invention relates to an enzymatic process for elongating gluco-oligosaccharides with a glucosyl moiety. The invention also relates to the elongated gluco-oligosaccharides obtained with the process. These elongated gluco-oligo...  
WO/2023/039293A9
Provided herein are coumarin derivatives of sugar analogs which are used to measure the rate of hydrolysis of these sugar analogs when contacted with a glycosidase. The reactivity of the coumarin derivatives serves as a convenient method...  
WO/2023/059530A1
Aspects of the disclosure relate to methods of using oligosaccharide compositions as microbiome metabolic therapies for treating inflammatory lung diseases and disorders, such as chronic obstructive pulmonary disease (COPD) and asthma.  
WO/2023/049853A1
The present invention features compositions and methods for the repair of myelin and/or treatment of demyelinating diseases. The demyelinating disease may be multiple sclerosis (MS), optic neuritis, myelin oligodendrocyte glycoprotein an...  
WO/2023/038517A1
The invention relates to a saponin derivative based on a saponin comprising a triterpene aglycone and at least one of a first saccharide chain and a second saccharide chain linked to the aglycone core structure, wherein the saponin deriv...  
WO/2023/028377A1
Disclosed are co-solvents as well as methods of using thereof in oil and gas operations. Described herein are also methods of displacing an unrefined petroleum material in contact with a solid material, said method comprising: contacting...  
WO/2023/018345A1
The invention relates to a method of producing an agent for purifying wastewater from municipal purification plants and from the chemical, food and livestock industries. The invention makes it possible to increase the degree of purificat...  
WO/2023/014927A1
Disclosed herein are prodrugs of tapinarof and pharmaceutical formulations comprising tarpinarof, such as oral formulations. Further disclosed herein are methods for treating diseases and disorders of the gastrointestinal tract, skin, ey...  
WO/2023/010010A1
Compositions, methods, systems and equipment capable of significantly reducing glyphosate, microbial, mycotoxin and other contaminant levels in various food commodities, such as, but not limited to, grains (e.g., corn, wheat, oats barley...  
WO/2023/002354A1
The present invention relates to new synthetic molecules with agonist activity of human Toll-like Receptor 4 (TLR4), compositions comprising them and uses thereof for the treatment of diseases in which it is useful to induce or increase ...  
WO/2023/002452A1
The present application provides synthetic processes for preparing N-acetyl-galactosamines (NAG) based compounds for targeted drug delivery. Also disclosed are Poly-NAG compounds, intermediates and targeting ligands, which are used and/o...  
WO/2023/284848A1
The present invention relates to the field of biotechnology, and specifically discloses fructooligosaccharide having high kestose content and an application thereof. In the fructooligosaccharide having high kestose content in the present...  
WO/2022/263718A1
The present invention relates to a method for producing cationic saccharide comprising providing a mixture comprising betaine aldehyde and a saccharide;allowing the betaine aldehyde to react with the saccharide; and obtaining cationic sa...  
WO/2022/266359A1
This disclosure relates to a product, a beverage product, and an infusion formulation that each include at least two rare sugars, for example allulose and tagatose. The combination of allulose and tagatose synergistically sweeten the pro...  

Matches 1 - 50 out of 3,257